Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-01-04 @ 9:30 AM
Study NCT ID:
NCT07156435
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2025-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vyxeos® With Clofarabine for Pediatric AML
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ITCC-092
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |